These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 38286060

  • 1. Efficacy of a spot-on formulation containing 280 mg/ml fluralaner and 14 mg/ml moxidectin (Bravecto® Plus) in the prevention of cat aelurostrongylosis under field conditions.
    Di Cesare A, Morelli S, Rohdich N, Kirkova Z, Capári B, Loehlein W, Wolf O, Zschiesche E, Colombo M, Astuti C, Traversa D.
    Vet Parasitol; 2024 Apr; 327():110114. PubMed ID: 38286060
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of Bravecto® Plus spot-on solution for cats (280 mg/ml fluralaner and 14 mg/ml moxidectin) for the prevention of aelurostrongylosis in experimentally infected cats.
    Raue K, Rohdich N, Hauck D, Zschiesche E, Morelli S, Traversa D, Di Cesare A, Roepke RKA, Strube C.
    Parasit Vectors; 2021 Feb 16; 14(1):110. PubMed ID: 33593394
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of Bravecto® Plus spot-on solution for cats (280 mg/ml fluralaner and 14 mg/ml moxidectin) in the prevention of feline Aelurostrongylus abstrusus infection evaluated in a multi-diagnostic approach.
    Raulf MK, Raue K, Rohdich N, Zschiesche E, Raue J, Merhof K, Volk HA, Schnyder M, Morelli S, Traversa D, Roepke RKA, Strube C.
    Parasit Vectors; 2024 Apr 24; 17(1):193. PubMed ID: 38658960
    [Abstract] [Full Text] [Related]

  • 4. A randomized, blinded, controlled, multi-centered field study assessing the treatment of gastrointestinal nematode infections in cats with fluralaner plus moxidectin spot-on solution (Bravecto® Plus).
    Rohdich N, Zschiesche E, Wolf O, Loehlein W, Kirkova Z, Iliev P, Rapti D, Postoli R, Capári B, Farkas R, Roepke RKA.
    Parasit Vectors; 2018 Nov 19; 11(1):589. PubMed ID: 30449275
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of a spot-on combination of fluralaner plus moxidectin (Bravecto® Plus) in cats following repeated experimental challenge with a field isolate of Ctenocephalides felis.
    Fisara P, Guerino F, Sun F.
    Parasit Vectors; 2019 May 23; 12(1):259. PubMed ID: 31122282
    [Abstract] [Full Text] [Related]

  • 6. Field effectiveness and safety of fluralaner plus moxidectin (Bravecto® Plus) against ticks and fleas: a European randomized, blinded, multicenter field study in naturally-infested client-owned cats.
    Rohdich N, Zschiesche E, Wolf O, Loehlein W, Pobel T, Gil MJ, Roepke RKA.
    Parasit Vectors; 2018 Nov 19; 11(1):598. PubMed ID: 30454052
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of fluralaner plus moxidectin (Bravecto® Plus spot-on solution for cats) against Otodectes cynotis infestations in cats.
    Taenzler J, de Vos C, Roepke RKA, Heckeroth AR.
    Parasit Vectors; 2018 Nov 19; 11(1):595. PubMed ID: 30449272
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of imidacloprid 10%/moxidectin 1% spot-on formulation (Advocate®) in the prevention and treatment of feline aelurostrongylosis.
    Heuer L, Petry G, Pollmeier M, Schaper R, Deuster K, Schmidt H, Blazejak K, Strube C, Di Cesare A, Traversa D, Schnyder M, McKay-Demeler J, von Samson-Himmelstjerna G, Mangold-Gehring S, Böhm C.
    Parasit Vectors; 2020 Feb 12; 13(1):65. PubMed ID: 32051008
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of two topical fluralaner formulations (Bravecto®; Bravecto® Plus) against Asian longhorned tick (Haemaphysalis longicornis) infestations of cats.
    Petersen M, Maree R, Pretorius H, Liebenberg JE, Guerino F.
    Parasit Vectors; 2023 Jan 26; 16(1):36. PubMed ID: 36703156
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of Emodepside/Praziquantel Spot-on (Profender®) against adult Aelurostrongylus abstrusus Nematodes in Experimentally Infected Cats.
    Böhm C, Wolken S, Schnyder M, Basso W, Deplazes P, Di Cesare A, Deuster K, Schaper R.
    Parasitol Res; 2015 Aug 26; 114 Suppl 1():S155-64. PubMed ID: 26152416
    [Abstract] [Full Text] [Related]

  • 11. Safety of topical administration of fluralaner plus moxidectin concurrently with praziquantel in cats.
    Walther FM, Fisara P, Roepke RKA.
    Parasit Vectors; 2018 Nov 19; 11(1):597. PubMed ID: 30454033
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of three consecutive monthly doses of a topical formulation of selamectin and sarolaner (Revolution® Plus/Stronghold® Plus) compared with a single dose of fluralaner (Bravecto® for Cats) against induced infestations of Ctenocephalides felis on cats.
    Vatta AF, King VL, Young DR, Chapin S.
    Vet Parasitol; 2019 Jun 19; 270 Suppl 1():S52-S57. PubMed ID: 31133494
    [Abstract] [Full Text] [Related]

  • 13. Comparative efficacy of topical treatments with Revolution® Plus (selamectin and sarolaner) and Bravecto® for Cats (fluralaner) against Ixodes scapularis ticks on cats.
    Vatta AF, Young DR, King VL, Myers MR.
    Vet Parasitol; 2019 Jun 19; 270 Suppl 1():S58-S63. PubMed ID: 31182302
    [Abstract] [Full Text] [Related]

  • 14. Comparative efficacy of a new spot-on combination product containing selamectin and sarolaner (Stronghold®Plus) versus fluralaner (Bravecto®) against induced infestations with Ixodes ricinus ticks on cats.
    Geurden T, Borowski S, Wozniakiewicz M, King V, Fourie J, Liebenberg J.
    Parasit Vectors; 2017 Jun 29; 10(1):319. PubMed ID: 28662690
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of imidacloprid 10%/moxidectin 1% spot-on formulation in the treatment of feline aelurostrongylosis.
    Traversa D, Di Cesare A, Milillo P, Lohr B, Iorio R, Pampurini F, Schaper R, Paoletti B, Heine J.
    Parasitol Res; 2009 Aug 29; 105 Suppl 1():S55-62. PubMed ID: 19575226
    [Abstract] [Full Text] [Related]

  • 16. Shedding of feline lungworm larvae and their infectivity to snail intermediate hosts after anthelmintic treatment.
    Cavalera MA, Colella V, Napoli E, Arfuso F, Panarese R, Brianti E, Otranto D.
    Int J Parasitol; 2019 May 29; 49(6):449-453. PubMed ID: 30904621
    [Abstract] [Full Text] [Related]

  • 17. Controlled field study evaluating the clinical efficacy of a topical formulation containing emodepside and praziquantel in the treatment of natural cat aelurostrongylosis.
    Crisi PE, Di Cesare A, Traversa D, Vignoli M, Morelli S, Di Tommaso M, De Santis F, Pampurini F, Schaper R, Boari A.
    Vet Rec; 2020 Sep 05; 187(5):e34. PubMed ID: 31754046
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of a moxidectin/imidacloprid spot-on formulation (Advocate®) for the treatment of Troglostrongylus brevior in naturally infected cats in a field study in Greece.
    Diakou A, Morelli S, Dimzas D, Di Cesare A, Capelli G, Parrinello C, Pollmeier M, Schaper R, Traversa D.
    Parasit Vectors; 2019 Nov 04; 12(1):519. PubMed ID: 31685011
    [Abstract] [Full Text] [Related]

  • 19. A Comparison of Copromicroscopic and Molecular Methods for the Diagnosis of Cat Aelurostrongylosis.
    Morelli S, Traversa D, Diakou A, Colombo M, Russi I, Mestek A, Chandrashekar R, Beall M, Paoletti B, Iorio R, Tsokana A, De Cristofaro D, Barlaam A, Simonato G, Di Cesare A.
    Animals (Basel); 2022 Apr 14; 12(8):. PubMed ID: 35454269
    [Abstract] [Full Text] [Related]

  • 20. Clinical efficacy of a parasiticide formulation containing eprinomectin, esafoxolaner and praziquantel (NexGard® Combo) in the treatment of natural feline aelurostrongylosis and troglostrongylosis.
    Di Cesare A, Veronesi F, Crisi PE, Colombo M, Morelli S, Vignoli M, Rigamonti G, Iorio R, Tielemans E, Beugnet F, Gamblin C, Traversa D.
    Vet Parasitol; 2024 Oct 14; 331():110271. PubMed ID: 39089177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.